OPTIKIRA
OptiKira develops novel therapeutics intended to prevent cell death. It targets UPR and regulates its activity to prevent cell degeneration in idiopathic pulmonary fibrosis, nonalcoholic steatohepatitis, diabetes, cancer,, and various neurodegenerative diseases, enabling medical practitioners to treat Retinitis pigmentosa, amyotrophic lateral sclerosis, and other chronic diseases. OptiKira was founded in 2014 and is headquartered in Cleveland, Ohio.
OPTIKIRA
Industry:
Eyewear Health Care Medical Therapeutics
Founded:
2014-01-01
Address:
Cleveland, Ohio, United States
Country:
United States
Website Url:
http://www.optikira.com
Total Employee:
1+
Status:
Active
Contact:
(216)455-3216
Email Addresses:
[email protected]
Total Funding:
8.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager Content Delivery Network Global Site Tag Euro Typekit Squarespace Squarespace Add To Cart
Similar Organizations
Avivomed
Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Enchroma
EnChroma develops eyewear for color blind people to improve human color vision.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Kaio Therapy
Kaio Therapy develops a novel hyperthermia system that delivers controlled heat at the cellular level within a tumor.
Oncology Therapeutics Network
Oncology Therapeutics Network
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Symbiotix Biotherapies
Symbiotix Biotherapies is a provider of a novel class of molecular therapeutics intended to develop molecules.
Theradaptive
Theradaptive develops targeted therapeutics using its proprietary THX1 platform
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Current Employees Featured
Founder
Official Site Inspections
http://www.optikira.com
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
